Medicines news January 2020
Medicines News January 2020
New medicines
tetracosactide solution for injection for dogs (brand name Cosacthen –Dechra). For the evaluation of adrenocortical function in dogs. POM-V. The marketing authorisation holder for this product, Dechra currently supplies an unauthorised form of tetracosactide (a veterinary special). When we called Dechra to find out about the new product, they did not say if, or when, the licensed product will be available in the UK and replace the special.
firocoxib chewable tablets for dogs (Firodyl – Ceva). For the relief of pain and inflammation associated with osteoarthritis in dogs. For the relief of post-operative pain and inflammation associated with soft-tissue, orthopaedic and dental surgery in dogs. POM-V A new brand of firocoxib in addition to Previcox.
myxomatosis and rabbit haemorrhagic disease virus (live) vaccine (Nobivac Myxo-RHD PLUS Lyophilisate and Solvent – Intervet). For active immunisation of rabbits from 5 weeks of age onwards to reduce mortality and clinical signs of myxomatosis and to prevent mortality due to rabbit haemorrhagic disease (RHD) caused by classical RHD virus strains. (distribution category not yet published). Nobivac Myxo-RHD Plus is the successor vaccine of the EU centrally licensed product Nobivac MyxoRHD. It was developed to provide protection against the newly emerging variant of RHDV, RHDV type 2, against which the protection conferred by the already authorised vaccines was not sufficient. Nobivac Myxo-RHD Plus contains two myxoma-vectored rabbit haemorrhagic disease strains: the classical strain 009 and variant strain MK1899. The myxoma virus is vectored with the respective VP60 protein of the RHDV strains; both strains are included in the vaccine and therefore protection against myxomatosis and both RHDV strains is conferred.
Changes to prescribing information
Aurimic Ear Drops and cutaneous suspension for dogs and cats (miconazole + polymyxin B + prednisolone acetate) Section 4.5 of the SPC (Special precautions) amended to include: ‘In cases of persistent infestations with Otodectes cynotis (ear mites) systemic treatment with an appropriate acaricide should be considered.’ Addition of the following warning to section 4.9 (dose and route of administration): ‘The success of the treatment should be verified by a veterinarian before discontinuing treatment.’
Broadline spot- on solution for cats
((S)-methoprene; eprinomectin; fipronil; praziquantel) Section 4.6 of the SPC (adverse effects) has been updated to include: ‘Transitory blindness or impaired vision have been observed in very rare cases based on post marketing safety experience.’
Updated Parasiticide Guide
We have just updated the companion animal Parasiticide Guide to include new products and new indications, and to delete unavailable products. Don’t forget, the Parasiticide Guide has many uses: you can find out which products suit a specific animal’s needs, check the ingredients in brands that your clients have bought over the counter, use it to build a practice parasiticide formulary, or use it just to help get your head around the confusing array of products on the market.
Our purpose...
......is to provide busy veterinary professionals with impartial information on veterinary medicines with which to make treatment decisions in the best interests of animals, their owners and the environment. We mainly do this through the Virtual Veterinary Medicines Academy where our evidence-based peer-reviewed appraisals are the result of a rigorous research and editorial process and are presented succinctly in our multi-media CPD modules. We’re independent: we don’t sell ads, or receive commercial support. We’re funded by subscribers so you can be sure the information we provide is completely objective. Subscribers get unlimited access to the Virtual Veterinary Medicines Academy.